Endoluminal Suturing Devices Market

Endoluminal Suturing Devices Market Size

The global endoluminal suturing devices market size was valued at USD 79.3 million in 2024 and is expected to exhibit growth at a CAGR of 17.5% from 2025 to 2034. The market is driven by advancements in minimally invasive surgical techniques and the growing prevalence of gastrointestinal and bariatric surgeries.

The rising global obesity epidemic has increased the demand for endoluminal bariatric procedures, such as gastric bypass and revision surgeries, which often rely on suturing devices. Innovations in device technology, including improved visualization, enhanced manoeuvrability, and compatibility with robotic systems, have also contributed to their increased adoption by surgeons.

Another key driver is the rise in gastrointestinal disorders, such as ulcers and perforations, which require endoluminal interventions. These devices offer reduced procedural risks and faster recovery times compared to traditional surgical methods, aligning with the broader healthcare trend toward minimally invasive solutions. Additionally, the integration of endoluminal suturing devices with advanced endoscopic systems enhances procedural precision and outcomes.

The growing focus on outpatient procedures, particularly in cost-conscious healthcare markets, is driving demand for these devices in ambulatory surgical centers. Furthermore, the expanding range of applications, such as endoscopic sleeve gastroplasty (ESG) and transoral fundoplication for GERD, is broadening their market potential. Government and private investments in healthcare infrastructure, particularly in emerging economies, are creating new opportunities for market growth. Together, these factors are fueling the global expansion of the endoluminal suturing devices market.

Endoluminal suturing devices are specialized medical tools designed to place sutures during minimally invasive endoscopic procedures. These devices facilitate internal tissue approximation, repair, and fixation through the gastrointestinal lumen, and are commonly used in bariatric surgery, gastroesophageal reflux disease (GERD) treatments, and the management of gastrointestinal perforations or fistulas.

Endoluminal Suturing Devices Market Trends

The rising prevalence of chronic diseases worldwide is a key driver for the growth of the market. Conditions such as obesity, gastroesophageal reflux disease (GERD), and gastrointestinal disorders are becoming more common due to lifestyle changes, unhealthy diets, and sedentary habits.

• Obesity, in particular, is a significant global health issue. According to the World Health Organization (WHO), in 2022, 2.5 billion adults (18 years and older) were overweight, with 890 million living with obesity. Endoluminal suturing devices play a crucial role in minimally invasive bariatric procedures like endoscopic sleeve gastroplasty (ESG), which provides effective weight loss and obesity management solutions with fewer risks compared to traditional surgeries.
  
• GERD and other gastrointestinal issues, often linked to chronic diseases, are also on the rise, driving the demand for advanced therapeutic options. Endoluminal suturing devices are vital in procedures like transoral incisionless fundoplication, which offers relief from GERD symptoms without the need for open surgery.
  
  
• Additionally, chronic conditions such as diabetes and cardiovascular diseases often require minimally invasive interventions to manage related complications, further increasing the adoption of these devices.
  
• Healthcare systems worldwide are focusing on cost-effective, minimally invasive solutions to address the growing burden of chronic diseases, particularly in aging populations. Endoluminal suturing devices, which help reduce surgical risks, hospital stays, and recovery times, align well with these needs.
  
• This combination of rising chronic disease prevalence and the demand for innovative, minimally invasive treatment options is driving the robust growth of the market.
  

Endoluminal Suturing Devices Market Analysis

Based on product type, the market is bifurcated as single use and reusable. The single use segment is expected to drive business growth and expand at a CAGR of 17.2%, reaching over USD 203 million by 2034.

• Single-use devices eliminate the risks associated with cross-contamination and surgical site infections (SSIs), which are critical concerns in minimally invasive procedures. This makes them particularly attractive in hospitals and ambulatory surgical centers where strict hygiene standards are enforced.
  
• Additionally, single-use devices require no sterilization, reducing operational costs and time, while ensuring immediate availability during procedures.
  
• The rapid adoption of minimally invasive procedures, combined with the increasing prevalence of gastrointestinal and bariatric surgeries, further boosts the demand for single-use devices. These devices are often pre-assembled and ready for use, improving procedural efficiency and reducing complexity for surgeons. Healthcare providers, particularly in developed markets, are shifting toward disposable options due to regulatory preferences for single-use medical devices.
  
• As healthcare systems worldwide aim to balance cost and efficiency with superior patient outcomes, the adoption of single-use suturing devices is expected to rise significantly, driving their market growth at a robust CAGR.
  

Based on application, the endoluminal suturing devices market is segmented as gastrointestinal defects, bariatric surgery, gastroesophageal reflux disease (GERD), and other applications. The gastrointestinal defects segment is expected to drive business growth and expand at a CAGR of 17.6%, reaching over USD 169.6 million by 2034.

• The growth is driven by the increasing prevalence of gastrointestinal conditions such as perforations, ulcers, and fistulas, often linked to dietary habits, stress, and chronic illnesses. These conditions require effective, minimally invasive treatment options, and endoluminal suturing devices offer a precise and efficient solution.
  
• Advancements in endoscopic techniques and suturing technologies have significantly improved procedural outcomes for gastrointestinal defects, making these devices a preferred choice among healthcare providers. Their ability to reduce operative risks, minimize recovery times, and lower hospital costs aligns with the rising demand for outpatient procedures.
  
• Furthermore, growing awareness and early diagnosis of gastrointestinal conditions are fueling procedural volumes, especially in developed regions with advanced healthcare systems.
  

Based on end use, the endoluminal suturing devices market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 59.2% in 2024.

• Hospitals are primary centers for advanced surgical and therapeutic interventions, making them the largest consumers of cutting-edge medical technologies, including endoluminal suturing devices. They have the infrastructure needed for complex endoscopic and minimally invasive procedures, such as bariatric surgeries and treatments for gastroesophageal reflux disease (GERD), which heavily utilize these devices.
  
• Hospitals also benefit from access to skilled endoscopists and surgeons, ensuring the successful adoption and utilization of endoluminal suturing systems. Furthermore, many hospitals are integrating robotic-assisted platforms with suturing devices, improving procedural efficiency and patient outcomes.
  
• The availability of insurance coverage for hospital-based procedures in many regions also incentivizes patients to seek treatment at these facilities. These factors contribute to the dominance of hospitals in the market.
  

The U.S. endoluminal suturing devices market accounted for USD 27.4 million in 2024 and is anticipated to grow at a CAGR of 16.6% between 2025 to 2034 period.

• Rising obesity rates in the U.S., among the highest globally, have increased the demand for minimally invasive bariatric procedures, such as endoscopic sleeve gastroplasty. Endoluminal suturing devices are central to these procedures, offering effective weight management solutions.
  
• Additionally, the prevalence of gastrointestinal conditions like gastroesophageal reflux disease (GERD), ulcers, and gastrointestinal perforations is rising, driven by lifestyle factors and aging demographics. These trends require advanced therapeutic interventions, for which endoluminal suturing devices are well-suited.
  
• The U.S. healthcare system's focus on outpatient and ambulatory care, driven by cost containment and patient convenience, further supports the adoption of these minimally invasive devices. Favorable reimbursement policies for minimally invasive gastrointestinal procedures also contribute to market growth.
  
• Moreover, the U.S. is home to key market players and research institutions that continuously drive innovation in this field. Increased investments in healthcare infrastructure and growing awareness among patients and providers about minimally invasive surgical options further reinforce market expansion.
  

U.K. endoluminal suturing devices market is projected to grow remarkably in the coming years.

• The increasing prevalence of obesity and related conditions, such as gastroesophageal reflux disease (GERD), is driving demand for these devices, particularly in bariatric and gastrointestinal surgeries. The NHS has been promoting cost-effective, less invasive treatments, aligning with the capabilities of endoluminal suturing devices to reduce hospital stays and recovery times.
  
• Additionally, the U.K.'s focus on integrating cutting-edge medical technologies supports the adoption of advanced endoluminal suturing systems, which provide greater precision and efficiency.
  
• With a growing emphasis on improving patient outcomes and reducing healthcare costs, these devices are becoming a cornerstone in managing complex gastrointestinal and metabolic disorders. Enhanced training programs and greater awareness among healthcare professionals about the advantages of these devices further contribute to market growth.
  
• Moreover, the U.K.'s active role in medical innovation and clinical trials is boosting the availability and adoption of state-of-the-art suturing solutions, enabling rapid market growth in the coming years.
  

China holds a dominant position in the Asia Pacific endoluminal suturing devices market.

• The country's rising prevalence of obesity and gastrointestinal disorders, driven by lifestyle changes and urbanization, has significantly increased the demand for minimally invasive surgical solutions. China also benefits from expanding healthcare infrastructure, with substantial investments in advanced medical technologies to support its aging population and growing burden of chronic diseases.
  
• Government initiatives, such as the Healthy China 2030 plan, emphasize the adoption of innovative healthcare solutions, boosting the market for devices like endoluminal suturing systems. The country's role as a global manufacturing hub allows for cost-effective production, making these devices more accessible both domestically and internationally.
  
• Additionally, China's skilled healthcare workforce and the rapid adoption of cutting-edge technologies, including robotic-assisted surgery and advanced endoscopic techniques, support market growth.
  

Endoluminal Suturing Devices Market Share

In the competitive landscape of the market, several companies dominate the industry, with notable players holding significant market share. These companies are leveraging their established product portfolios and ongoing innovations to expand their presence. These players are expected to continue dominating the market due to their robust distribution networks, technological advancements, and the rising preference for minimally invasive surgeries. As the market grows, these companies will likely face increased competition from newer entrants, although their strong brand recognition and innovation pipelines position them well for long-term growth.

Endoluminal Suturing Devices Market Companies

Prominent players operating in the endoluminal suturing devices industry include:

• Apollo Endosurgery
• Boston Scientific
• Braun Melsungen
• Cook Group
• Endo Tools Therapeutics
• ErgoSuture
• Johnson and Johnson
• Karl Storz
• Medtronic
• Olympus Corporation
• Ovesco Endoscopy
• Richard Wolf
• Teleflex Corporation
• Terumo Corporation
• USGI Medical
  

Endoluminal Suturing Devices Industry News:

• In November 2023, Johnson and Johnson MedTech’s Ethicon division unveiled the ETHIZIA Hemostatic Sealing Patch, a cutting-edge solution designed to address challenging bleeding conditions. This patch features an innovative synthetic polymer technology, making it the first hemostatic matrix that is equally effective on both sides. The product has been granted CE Mark approval for use on internal organs, excluding applications related to cardiovascular and neurological areas.
  
• In December 2021, Endo Tools Therapeutics S.A. received FDA 510(k) clearance for its Endomina System, enhancing its position in the medical device market.  
  

The endoluminal suturing devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Single use
• Reusable

Market, By Application

• Gastrointestinal defects
• Bariatric surgery
• Gastroesophageal reflux disease (GERD)
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE